Clinical Trials Browser

Terminated × Uterine Cervical Neoplasms × olaparib × Clear all

NCT04483544 2025-04-29

Pembrolizumab and Olaparib in Cervical Cancer Patients

Phase 2 Terminated

8 enrolled 13 charts

Uterine Cervical Neoplasms